Stocktoria
Jaguar Health, Inc. JAGX
Jaguar Health, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.5M | $11.7M | $9.8M | $12.0M | $4.3M | $9.4M | $5.8M | $4.4M | $4.4M | $141,523 |
| R&D expense | $25.0M | $16.5M | $18.6M | $17.6M | $15.1M | $6.4M | $5.8M | $5.2M | $4.3M | $7.2M |
| Operating income | -$45.9M | -$30.8M | -$34.3M | -$34.4M | -$40.7M | -$26.6M | -$28.9M | -$30.8M | -$34.2M | -$13.6M |
| Interest expense | $67,000 | $231,000 | $6.4M | $12.7M | $8.4M | $2.8M | $5.7M | $2.6M | $1.2M | $985,549 |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $10,000 | — | -$13.2M | — |
| Net income | -$53.6M | -$38.5M | -$41.3M | -$47.5M | — | -$33.8M | -$38.5M | -$32.1M | -$22.0M | -$14.7M |
| EPS (diluted) | $-22.97 | $-130.69 | $-2678.17 | $-36.18 | $-88.22 | $-3.00 | — | — | — | — |
| Operating cash flow | -$23.7M | -$29.4M | -$33.2M | -$33.1M | -$35.0M | -$15.3M | -$20.5M | -$22.7M | -$9.8M | -$14.4M |
| Free cash flow | — | -$29.4M | — | -$33.2M | -$35.0M | -$15.3M | — | -$22.7M | — | -$14.5M |
| Cash & equivalents | $968,000 | $8.0M | $6.5M | $5.5M | $17.1M | $8.1M | $3.5M | $2.6M | $520,698 | $950,979 |
| Inventory | $8.6M | $10.3M | $9.2M | $7.0M | $4.9M | $2.8M | $2.1M | $3.3M | $2.1M | $412,754 |
| Total assets | $38.3M | $53.4M | $50.8M | $47.5M | $53.3M | $42.8M | $36.4M | $41.0M | $43.6M | $3.6M |
| Total liabilities | $57.0M | $44.4M | $45.9M | $48.8M | $41.4M | $25.6M | $15.8M | $26.7M | $26.4M | $6.0M |
| Shareholders' equity | -$18.7M | $6.5M | $4.9M | -$1.4M | $11.9M | $17.2M | $10.7M | $5.4M | $17.3M | -$2.5M |
Growth · year-over-year · Revenue CAGR 63%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -1.5% | +19.8% | -18.4% | +175.8% | -53.8% | +62.5% | +30.8% | +1.3% | +2981.6% | -45.2% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.